136 related articles for article (PubMed ID: 1863444)
1. Gender influences subsite of origin of laryngeal carcinoma.
Stephenson WT; Barnes DE; Holmes FF; Norris CW
Arch Otolaryngol Head Neck Surg; 1991 Jul; 117(7):774-8. PubMed ID: 1863444
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological Study of Laryngeal Carcinoma in Western Nepal.
Koirala K
Asian Pac J Cancer Prev; 2015; 16(15):6541-4. PubMed ID: 26434871
[TBL] [Abstract][Full Text] [Related]
3. Supraglottic versus glottic laryngeal cancer: epidemiological and pathological aspects.
Silvestri F; Bussani R; Stanta G; Cosatti C; Ferlito A
ORL J Otorhinolaryngol Relat Spec; 1992; 54(1):43-8. PubMed ID: 1584591
[TBL] [Abstract][Full Text] [Related]
4. Progress against laryngeal cancer in The Netherlands between 1989 and 2010.
van Dijk BA; Karim-Kos HE; Coebergh JW; Marres HA; de Vries E
Int J Cancer; 2014 Feb; 134(3):674-81. PubMed ID: 23873096
[TBL] [Abstract][Full Text] [Related]
5. Glottic and supraglottic laryngeal carcinoma: differences in epidemiology, clinical characteristics and prognosis.
Raitiola H; Pukander J; Laippala P
Acta Otolaryngol; 1999; 119(7):847-51. PubMed ID: 10687946
[TBL] [Abstract][Full Text] [Related]
6. [A clinical study of 1079 patients with laryngeal cancer].
Fujii T; Sato T; Yoshino K; Inakami K; Nagahara M; Okita J
Nihon Jibiinkoka Gakkai Kaiho; 1997 Aug; 100(8):856-63. PubMed ID: 9293766
[TBL] [Abstract][Full Text] [Related]
7. Is the subsite distribution of laryngeal cancer related to smoking habits?
Virtaniemi JA; Hirvikoski PP; Kumpulainen EJ; Johansson RT; Pukkala E; Kosma VM
Acta Oncol; 2000; 39(1):77-9. PubMed ID: 10752658
[TBL] [Abstract][Full Text] [Related]
8. Comparative estimation of cure rates for supraglottic and glottic cancer in radiotherapy.
Goleń M; Składowski K; Maciejewski B
Neoplasma; 1999; 46(1):66-71. PubMed ID: 10355537
[TBL] [Abstract][Full Text] [Related]
9. The management of glottic and supraglottic cancers of the larynx in relation to neck metastasis.
Yücetürk AV; Celik O; Eskiizmir G
Kulak Burun Bogaz Ihtis Derg; 2003 Nov; 11(5):129-33. PubMed ID: 15542939
[TBL] [Abstract][Full Text] [Related]
10. Differences in the sex ratio of laryngeal cancer incidence rates by anatomic subsite.
Yang PC; Thomas DB; Daling JR; Davis S
J Clin Epidemiol; 1989; 42(8):755-8. PubMed ID: 2788212
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years.
Tamura Y; Tanaka S; Asato R; Hirano S; Yamashita M; Tamaki H; Ito J
Acta Otolaryngol Suppl; 2007 Feb; (557):62-5. PubMed ID: 17453448
[TBL] [Abstract][Full Text] [Related]
12. Gender-related incidence, risk factors exposure and survival rates of laryngeal cancers - the 10-years analysis of trends from one institution.
Majszyk D; Bruzgielewicz A; Osuch-Wójcikiewicz E; Rzepakowska A; Niemczyk K
Otolaryngol Pol; 2019 Apr; 73(3):6-10. PubMed ID: 31249148
[TBL] [Abstract][Full Text] [Related]
13. Primary radiotherapy of T1 squamous cell carcinoma of the larynx: analysis of 478 patients treated from 1963 to 1985.
Johansen LV; Overgaard J; Hjelm-Hansen M; Gadeberg CC
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1307-13. PubMed ID: 2370181
[TBL] [Abstract][Full Text] [Related]
14. [Supraglottic and glottic carcinomas. Study of the incidence in the last 31 years].
Tamarit Conejeros JM; Carrasco Llatas M; Estellés Ferriol E; Fernández Martínez S; Baviera Granell N; Dalmau Galofre J
Acta Otorrinolaringol Esp; 2007 Dec; 58(10):449-53. PubMed ID: 18082073
[TBL] [Abstract][Full Text] [Related]
15. Supraglottic and glottic carcinomas: epidemiologically distinct entities?
De Stefani E; Boffetta P; Deneo-Pellegrini H; Brennan P; Correa P; Oreggia F; Ronco AL; Mendilaharsu M
Int J Cancer; 2004 Dec; 112(6):1065-71. PubMed ID: 15386361
[TBL] [Abstract][Full Text] [Related]
16. Impact of stage, management and recurrence on survival rates in laryngeal cancer.
Brandstorp-Boesen J; Sørum Falk R; Boysen M; Brøndbo K
PLoS One; 2017; 12(7):e0179371. PubMed ID: 28708883
[TBL] [Abstract][Full Text] [Related]
17. Glottic and supraglottic laryngeal cancer: epidemiology, treatment patterns and survival in 164 patients.
Petrakos I; Kontzoglou K; Nikolopoulos TP; Papadopoulos O; Kostakis A
J BUON; 2012; 17(4):700-5. PubMed ID: 23335528
[TBL] [Abstract][Full Text] [Related]
18. Survival Impact of Initial Therapy in Patients with T1-T2 Glottic Squamous Cell Carcinoma.
Brady JS; Marchiano E; Kam D; Baredes S; Eloy JA; Park RC
Otolaryngol Head Neck Surg; 2016 Aug; 155(2):257-64. PubMed ID: 27026735
[TBL] [Abstract][Full Text] [Related]
19. Glottic versus supraglottic tumors: differential molecular profile.
Kourelis K; Papadas T; Vandoros G; Goumas P; Sotiropoulou-Bonikou G
Eur Arch Otorhinolaryngol; 2008 Jan; 265(1):79-84. PubMed ID: 17909831
[TBL] [Abstract][Full Text] [Related]
20. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
